{"id":"W4412431037","doi":"10.1016/j.ejca.2025.115629","title":"Paediatric strategy forum for medicinal product development of cyclin-dependent kinase inhibitors in children and adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration","year":2025,"lang":"en","type":"review","venue":"European Journal of Cancer","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Agenzia Italiana del Farmaco, Ministero della Salute; Loxo Oncology; National Institutes of Health; Cambridge University Hospitals; Solving Kids' Cancer; College ter Beoordeling van Geneesmiddelen; G1 Therapeutics; Institut Gustave-Roussy; Amsterdam University Medical Centers; Deutsches Krebsforschungszentrum; B-IT Foundation; Uniwersytet Jagielloński Collegium Medicum; Bundesinstitut für Arzneimittel und Medizinprodukte; National Cancer Center Japan; Karolinska Institutet; University of Minnesota; Memorial Sloan-Kettering Cancer Center; Centre Léon Bérard; Eli Lilly and Company; AstraZeneca; University of Cambridge; Children's Hospital of Philadelphia; Royal Marsden NHS Foundation Trust; Children's Hospital Colorado; Hospital for Sick Children; Pfizer","keywords":"Food and drug administration; Agency (philosophy); Product (mathematics); Drug; Medicine; Business; Regulatory agency; Pharmacology; Political science","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001332319,0.0002514475,0.0007167674,0.0002355071,0.00005230717,0.00001496243,0.0001457019,0.00002187242,0.000001636409],"category_scores_gemma":[0.00008373481,0.0001211266,0.0000472221,0.0005463928,0.0001364409,0.0001156165,0.00003634402,0.000306277,4.430607e-8],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000110475,"about_ca_system_score_gemma":0.001386678,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000004511593,"about_ca_topic_score_gemma":0.0004722497,"domain_scores_codex":[0.9975616,0.0005930587,0.001047944,0.0002246438,0.0004121911,0.0001605669],"domain_scores_gemma":[0.9977967,0.00005526847,0.001565114,0.0001605893,0.0003608687,0.00006151405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0005902321,0.00008867286,0.01076047,0.003405981,0.0001593818,0.0000103119,0.001211214,0.00006527953,0.00002373215,0.000002317053,0.00003469818,0.9836477],"study_design_scores_gemma":[0.01830338,0.004593009,0.7864893,0.1545218,0.003999596,0.000299916,0.002372658,0.000006908388,0.001741722,0.00001701499,0.02694313,0.0007115382],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1014132,0.895858,0.0001022249,0.0007173761,0.0001031613,0.001741493,0.00002439607,0.000002940787,0.00003714152],"genre_scores_gemma":[0.7157965,0.2836978,0.0001484336,0.0000343506,0.000234788,0.00002661137,0.000008395994,0.00003268275,0.00002040114],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.9829362,"threshold_uncertainty_score":0.4939398,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01851168105475782,"score_gpt":0.3160960032715867,"score_spread":0.2975843222168289,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}